Enterogenous infection of Candida albicans in immunocompromised rats under severe acute pancreatitis.

BACKGROUND Opportunistic infection of Candida albicans (C. albicans) has become a serious problem in immunocompromised patients. The study aimed to explore the mechanism of enterogenous infection of C. albicans in immunocompromised rats under severe acute pancreatitis (SAP). METHODS Sprague Dawley (SD) rats (n=100) were randomly assigned into 5 groups as the following: blank group, cyclophosphamide+ceftriaxone+SAP group, cyclophosphamide+ceftriaxone group, cyclophosphamide+SAP group, and cyclophosphamide group. The rats were sacrificed at 5 and 10 days, and their jejunum, colon, mesenteric lymph nodes, pancreas, intestinal content, and blood were quickly collected to detect C. albicans. A region of the 25S rRNA gene was chosen and amplified by polymerase chain reaction (PCR) to differentiate C. albicans genotypes. The amplified products were further sequenced and compared to judge their homology. RESULTS Compared with the Cyclophosphamide group, the combination of immunosuppressants and broad-spectrum antibiotics significantly increased the colonization of C. albicans in intestine in 5 and 10 days. Pure SAP stress did not increase the opportunistic infection of C. albicans. The PCR products of C. albicans isolates all belonged to the genotype A family, and sequence alignment showed that the amplified fragments were homologous. CONCLUSION The damage of immune system and broad-spectrum antimicrobial agents are important risk factors for opportunistic fungal infection. Intestinal tract is an important source for genotype-A C. albicans to translocate and invade into bloodstream.

[1]  Xiaozhong Zheng,et al.  The Intestinal Mucus Layer is a Critical Component of the Gut Barrier that is Damaged During Acute Pancreatitis , 2014, Shock.

[2]  E. Mao,et al.  Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai , 2014, BMC Infectious Diseases.

[3]  N. Yapar Epidemiology and risk factors for invasive candidiasis , 2014, Therapeutics and clinical risk management.

[4]  Yin-Tie Jin,et al.  Melatonin reduces bacterial translocation by preventing damage to the intestinal mucosa in an experimental severe acute pancreatitis rat model , 2013, Experimental and therapeutic medicine.

[5]  M. Petzold,et al.  Possible transmission of Candida albicans on an intensive care unit: genotype and temporal cluster analyses. , 2013, The Journal of hospital infection.

[6]  Chunhui Yang,et al.  Disruption of the intestinal mucosal barrier in Candida albicans infections. , 2013, Microbiological research.

[7]  H. Xie,et al.  The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis. , 2013, European review for medical and pharmacological sciences.

[8]  Qiong Zhang,et al.  Genotypic distribution of Candida albicans in dental biofilm of Chinese children associated with severe early childhood caries. , 2012, Archives of oral biology.

[9]  F. Chang,et al.  Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[10]  G. Hua,et al.  Early Gut Barrier Dysfunction in Patients with Severe Acute Pancreatitis: Attenuated by Continuous Blood Purification Treatment , 2010, The International journal of artificial organs.

[11]  İ. Kaleli,et al.  Molecular Analysis of Candida albicans Isolates from Clinical Specimens , 2010, Mycopathologia.

[12]  U. Sonnenborn,et al.  Yeasts in the gut: from commensals to infectious agents. , 2009, Deutsches Arzteblatt international.

[13]  J. Perfect,et al.  Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  A. Levin,et al.  Candida colonisation as a source for candidaemia. , 2009, The Journal of hospital infection.

[15]  T. Kanbe,et al.  Genotyping of Candida albicans by fragment analysis of microsatellites combined with 25S rDNA and RPS-based strategies. , 2009, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[16]  B. Millar,et al.  Frequency and distribution of group I intron genotypes of Candida albicans colonising critically ill patients , 2005, British journal of biomedical science.

[17]  N. Akar,et al.  Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness , 2004, Mycoses.

[18]  E. Anaissie,et al.  Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  K. Nishimura,et al.  Molecular Characterization of New Clinical Isolates ofCandida albicans and C. dubliniensis in Japan: Analysis Reveals a New Genotype of C. albicans with Group I Intron , 2001, Journal of Clinical Microbiology.

[20]  D. Stevens,et al.  Molecular and Phenotypic Characterization of Genotypic Candida albicans Subgroups and Comparison withCandida dubliniensis and Candida stellatoidea , 1999, Journal of Clinical Microbiology.

[21]  E. Anaissie,et al.  Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans , 1996, Antimicrobial agents and chemotherapy.

[22]  P. Nyström,et al.  Bacterial translocation during acute pancreatitis in rats. , 1993, The European journal of surgery = Acta chirurgica.